Cell differentiation and dominant signaling pathway signatures in the molecular classification of human breast cancer cell lines

Podobne knjige/članki

• Identification of common predictive markers of in vitro response to the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines
  od: Garon, Edward B., et al.
  Izdano: (2010)
• KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition
  od: Hamidi, H, et al.
  Izdano: (2014)
• PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
  od: Finn, Richard S, et al.
  Izdano: (2009)
• Histone signature of metanephric mesenchyme cell lines
  od: McLaughlin, Nathan, et al.
  Izdano: (2013)
• A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines
  od: Moreaux, Jérôme, et al.
  Izdano: (2011)